Reference LCIB-ARTICLE-2007-010doi:10.1021/cr030726oView record in Web of Science Record created on 2007-02-14, modified on 2017-05-12

Inorganic and bioinorganic solvent exchange mechanisms.

This Account summarizes the DNA binding properties of anticancer active dinuclear Rh, Re, and Ru compounds. The combined results of NMR spectroscopy, X-ray crystallography, and various biochemical tools provide incontrovertible evidence that dinuclear complexes are favorably poised to bind to purine nucleobases, DNA fragments, and double-stranded DNA. Moreover, direct DNA photocleavage in vitro is effected by dirhodium compounds in the presence of electron acceptors in solution or directly attached to the dirhodium core. This research has provided valuable insight in the interactions of dinuclear compounds with DNA, knowledge that is an excellent backdrop for rational design of promising dinuclear drugs.

Interactions of metal-metal-bonded antitumor active complexes with DNA fragments and DNA.

Molecular water-oxidation catalysts can deactivate by side reactions or decompose to secondary materials over time due to the harsh, oxidizing conditions required to drive oxygen evolution. Distinguishing electrode surface-bound heterogeneous catalysts (such as iridium oxide) from homogeneous molecular catalysts is often difficult. Using an electrochemical quartz crystal nanobalance (EQCN), we report a method for probing electrodeposition of metal oxide materials from molecular precursors. Using the previously reported [Cp*Ir(H(2)O)(3)](2+) complex, we monitor deposition of a heterogeneous water oxidation catalyst by measuring the electrode mass in real time with piezoelectric gravimetry. Conversely, we do not observe deposition for homogeneous catalysts, such as the water-soluble complex Cp*Ir(pyr-CMe(2)O)X reported in this work. Rotating ring-disk electrode electrochemistry and Clark-type electrode studies show that this complex is a catalyst for water oxidation with oxygen produced as the product. For the heterogeneous, surface-attached material generated from [Cp*Ir(H(2)O)(3)](2+), we can estimate the percentage of electroactive metal centers in the surface layer. We monitor electrode composition dynamically during catalytic turnover, providing new information on catalytic performance. Together, these data suggest that EQCN can directly probe the homogeneity of molecular water-oxidation catalysts over short times.

Distinguishing homogeneous from heterogeneous catalysis in electrode-driven water oxidation with molecular iridium complexes.

Simultaneous Tuning of Activity and Water Solubility of Complex Catalysts by Acid−Base Equilibrium of Ligands for Conversion of Carbon Dioxide

Organometallic compounds offer broad scope for the design of therapeutic agents, but this avenue has yet to be widely explored. A key concept in the design of anticancer complexes is optimization of chemical reactivity to allow facile attack on the target site (e.g., DNA) yet avoid attack on other sites associated with unwanted side effects. Here, we consider how this result can be achieved for monofunctional “piano-stool” ruthenium(II) arene complexes of the type [(η6-arene)Ru(ethylenediamine)(X)]n+. A potentially important activation mechanism for reactions with biomolecules is hydrolysis. Density functional calculations suggested that aquation (substitution of X by H2O) occurs by means of a concerted ligand interchange mechanism. We studied the kinetics and equilibria for hydrolysis of 21 complexes, containing, as X, halides and pseudohalides, pyridine (py) derivatives, and a thiolate, together with benzene (bz) or a substituted bz as arene, using UV-visible spectroscopy, HPLC, and electrospray MS. The x-ray structures of six complexes are reported. In general, complexes that hydrolyze either rapidly {e.g., X = halide [arene = hexamethylbenzene (hmb)]} or moderately slowly [e.g., X = azide, dichloropyridine (arene = hmb)] are active toward A2780 human ovarian cancer cells, whereas complexes that do not aquate (e.g., X = py) are inactive. An intriguing exception is the X = thiophenolate complex, which undergoes little hydrolysis and appears to be activated by a different mechanism. The ability to tune the chemical reactivity of this class of organometallic ruthenium arene compounds should be useful in optimizing their design as anticancer agents.

/pdf/controlling-ligand-substitution-reactions-of-organometallic-1zy2kzkwiw.pdf

Lynda Dadci

Papers

.pi.-Arene Aqua Complexes of Cobalt, Rhodium, Iridium, and Ruthenium: Preparation, Structure, and Kinetics of Water Exchange and Water Substitution

High-pressure proton NMR study of acetonitrile exchange kinetics on [Rh2(CH3CN)10]4+ and 17O NMR investigation of aqueous solutions of [Rh2(H2O)10]4 +